Tiger
Download
TigerAI
Help
LOGIN
SIGN UP
Toggle
A
ADiTx Therapeutics's 2023Q4 financial report review
US
ADTX
May15th Thursday
Post-market
Earnings Overview
Financial Data
Actual
YoY
Estimates
EPS
-368.20K
79.03%
-298.10K
Revenue
82.00K
-55.91%
136.00K
EBIT
-7.95M
3.04%
-6.07M
News
In-Depth Insights
The above content is machine - summarized based on the financial report. It is for reference only, does not constitute investment advice, and does not guarantee accuracy.
Market Insights
What's the highlight of ADiTx Therapeutics's financial report?
Talk to TigerAI
Start
Exclusive Benefits
Analyst Forecast
A
ADiTx Therapeutics
US
ADTX
May15th Thursday
Post-market
Analyst Price Targets
Data Last updated:
Analyst Recommendations
Relevant Information
Feedback
Welcome to share with us your comments or feedback
*T&Cs Apply. Capital at Risk, Not Investment Advice.
Learn more
{"basename":"/earnseason","ssrTDKData":{"titleTemplate":"%s","title":"Tiger Trade _ US, HK & SG stocks, ETFs & US options","description":"A top trading platform from a NASDAQ listed company enables investors to invest in the global giants from only USD 1, and here you can access to investment products including US stocks, SG stocks, HK stocks, ETFs, US options, US fractional shares & auto invest on multiple global markets including Nasdaq, New York Stock Exchange, Hong Kong Stock Exchange & Singapore Stock Exchange","keywords":"Tiger Trade,US stock trading,Hong Kong stock trading,Singapore trading,US stocks,top US stocks,stock information,stock prices,US stock quotes,buying US stocks,global investment,trading,trading platform,US options,ETFs","social":{"ogDescription":"A top trading platform from a NASDAQ listed company enables investors to invest in the global giants from only USD 1, and here you can access to investment products including US stocks, SG stocks, HK stocks, ETFs, US options, US fractional shares & auto invest on multiple global markets including Nasdaq, New York Stock Exchange, Hong Kong Stock Exchange & Singapore Stock Exchange","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigertrade.app/earnseason/ADTX"},"companyName":"Tiger"},"pageData":{"pageTitle":"ADiTx Therapeutics (ADTX) Earnings Calendar_Earnings Analysis_Financial Report and Earnings Call","headTitle":"ADiTx Therapeutics's 2023Q4 financial report review","feedBackDisplay":true,"financialNewsMaxNum":3,"keyData":[{"nameChs":"调整后每股收益","nameCht":"調整後每股收益","nameEng":"EPS","actualValue":-368200,"expectedValue":-298100,"yoyGrowth":0.79032,"name":"EPS"},{"nameChs":"收入","nameCht":"收入","nameEng":"Revenue","actualValue":82000,"expectedValue":136000,"yoyGrowth":-0.55914,"name":"Revenue"},{"nameChs":"息税前利润","nameCht":"息稅前利潤","nameEng":"EBIT","actualValue":-7951000,"expectedValue":-6071000,"yoyGrowth":0.03037,"name":"EBIT"}],"tigerGpt":{"internalJumpUrl":null,"externalJumpUrl":null},"beforeOrAfter":"after","shareConfig":{"socialMediaImage":"https://static.tigerbbs.com/461bf91ab2e2283e68395ea16fd95e8e","weChatImage":"https://static.tigerbbs.com/55353f4879f69c699f0109fe402ca704","title":"ADTX's Earnings Review","description":"View key performance metrics of ADTX's earnings in one chart and explore more opportunities."},"analystRecommendations":[{"market":"US","symbol":"ADTX","logo":null,"reportTime":"Post Market","isReport":true,"date":"20250515","nameEng":"ADiTx Therapeutics","timestamp":1747238400000,"name":"ADiTx Therapeutics"}],"stockInfo":{"market":"US","symbol":"ADTX","logo":null,"reportTime":"Post Market","isReport":true,"date":"20250515","timestamp":1747238400000,"name":"ADiTx Therapeutics","nameEng":"ADiTx Therapeutics"}},"pageError":null,"isTTM":true,"isTigerTrade":false,"isTigerTradeLite":false,"license":"TBMS","region":"IDN","edition":"full_ms","isOpenedInApp":true}